Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Cash from Investing (Quarterly): -0.006M for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.006M |
| March 31, 2023 | -12.56M |
| December 31, 2022 | -0.009M |
| September 30, 2022 | -11.24M |
| June 30, 2022 | -75.42M |
| March 31, 2022 | -0.168M |
| December 31, 2021 | -0.049M |
| September 30, 2021 | -0.005M |
| June 30, 2021 | 0.115M |
| March 31, 2021 | -5.384M |
| December 31, 2020 | -0.17M |
| September 30, 2020 | -0.201M |
| June 30, 2020 | 0.096M |
| March 31, 2020 | -17.97M |
| December 31, 2019 | -0.13M |
| September 30, 2019 | -0.304M |
| June 30, 2019 | -0.166M |
| March 31, 2019 | -0.177M |
| December 31, 2018 | -0.081M |
| September 30, 2018 | -0.033M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.019M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.73M |
| September 30, 2017 | -1.572M |
| June 30, 2017 | -0.208M |
| March 31, 2017 | -0.676M |
| December 31, 2016 | -27.62M |
| September 30, 2016 | -14.18M |
| June 30, 2016 | -0.10M |
| March 31, 2016 | -3.904M |
| December 31, 2015 | 23.52M |
| September 30, 2015 | 64.93M |
| June 30, 2015 | -74.28M |
| March 31, 2015 | -16.04M |
| December 31, 2014 | 19.99M |
| September 30, 2014 | -20.01M |
| June 30, 2014 | -0.0042M |
| March 31, 2014 | -0.0276M |
| December 31, 2013 | -0.007M |
| September 30, 2013 | -0.0103M |
| June 30, 2013 | -0.0307M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 1.50M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-75.42M
Minimum
Jun 2022
0.115M
Maximum
Jun 2021
-8.206M
Average
-0.168M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Verrica Pharmaceuticals Inc | -0.016M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.126M |
| Cash from Financing (Quarterly) | -6.411M |